SEGALL BRYANT & HAMILL, LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$9,783,000
+299.1%
130,011
+42.4%
0.11%
+378.3%
Q1 2022$2,451,000
-43.6%
91,331
+0.2%
0.02%
-42.5%
Q4 2021$4,346,000
-38.2%
91,120
-14.0%
0.04%
+17.6%
Q3 2021$7,038,000
+74.3%
105,950
+104.7%
0.03%
-12.8%
Q2 2021$4,038,000
-12.7%
51,763
+5.8%
0.04%
-15.2%
Q1 2021$4,628,000
-23.2%
48,939
-1.0%
0.05%
-31.3%
Q4 2020$6,023,000
+36.9%
49,436
-1.8%
0.07%
+11.7%
Q3 2020$4,398,000
+387.0%
50,343
+260.5%
0.06%
+300.0%
Q2 2020$903,000
+97.6%
13,964
+36.6%
0.02%
+66.7%
Q1 2020$457,000
+9.1%
10,223
+52.2%
0.01%
+50.0%
Q4 2019$419,0006,7150.01%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q4 2020.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders